Ulf Schneider - PAREXEL International President

PRXL -- USA Stock  

null 88.06  0.04  0.0454%

Dr. Ulf Schneider, Ph.D., is Chief Administrative Officer, Senior Vice President of Parexel International Corporationrationration since June 2000. From 1990 to 1992, he served as Director of Finance and Administration of PAREXEL Germany and from 1992 to 1996 he served as Vice President of Finance of PAREXEL Germany. Prior to joining PAREXEL, Dr. Schneider held several financial management positions at Schering AG, a pharmaceutical company, in Germany and was an Assistant Professor of Banking and Finance at the Berlin Technical University
Age: 57  President Since 2000      
781 487-9900  http://www.parexel.com
Schneider received his Masters degree in business administration and Ph.D. in business management from the Berlin Technical University.

Ulf Schneider Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 6.72 % which means that it generated profit of $6.72 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 16.93 % meaning that it created $16.93 on every $100 dollars invested by stockholders.
The company currently holds 671.5M in liabilities with Debt to Equity (D/E) ratio of 105.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PAREXEL International has Current Ratio of 1.42 which is within standard range for the sector.

Similar Executives

Showing few of many executives


John HendricksonPerrigo Company plc
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
Michael AbermanRegeneron Pharmaceuticals
Roxanne LaganoZoetis
Heidi ChenZoetis
Joseph LaRosaRegeneron Pharmaceuticals
Stefan WeiskopfZoetis
James MichaudPerrigo Company plc
John WesolowskiPerrigo Company plc
M RamanaDr Reddys Laboratories Ltd
Thomas GraneyVertex Pharmaceuticals Incorpor
Qiang GaoSinovac Biotech Ltd
Amit BiswasDr Reddys Laboratories Ltd
Louis YuPerrigo Company plc
Paul WeningerPerrigo Company plc
Michael PariniVertex Pharmaceuticals Incorpor
Ian SmithVertex Pharmaceuticals Incorpor
Michael StewartPerrigo Company plc
Peter PowchikRegeneron Pharmaceuticals
Alok SonigDr Reddys Laboratories Ltd
Marc CouckePerrigo Company plc

Entity Summary

PAREXEL International Corporationration, a biopharmaceutical services company, offer clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology solutions and services for pharmaceutical, biotechnology, and medical device industries worldwide. PAREXEL International Corp (PRXL) is traded on NASDAQ in USA and employs 18,600 people.

PAREXEL International Leadership Team

Michelle Graham, Chief Human Resource Officer, Senior Vice President
Ulf Schneider, Chief Administrative Officer, Senior Vice President
Thomas Senderovitz, Senior Vice President - Clinical Research Services
Dana Callow, Presiding Independent Director
Emma Reeve, Interim CFO, Corporate Vice President Controller
Josef Rickenbach, Founder, Chairman and CEO
Patrick Fortune, Independent Director
Eduard Holdener, Independent Director
Simon Harford, CFO, Senior Vice President
Joshua Schultz, Senior Vice President-Worldwide Head of PAREXEL Access
Gadi Saarony, Senior Vice President - Clinical Research Services
Ellen Zane, Director, Member of Compensation Committee, Member of HR Committee, CEO of Tufts Medical Center and President of Tufts Medical Center
Christian Dreger, Senior Vice President - Parexel Access and Parexel Consulting
Xavier Flinois, President - Perceptive Informatics
Douglas Batt, Sr. VP, General Counsel and Secretary
Sybrand Pretorius, Senior Vice President Chief Scientific Officer
Maykin Ho, Director
Richard Love, Independent Director
Ronald Aldridge, Sr. Director, Investor Relations
Mark Goldberg, President COO
Roland Andersson, Senior Vice President - Clinical Research Services
Christopher Lindop, Independent Director
Ingo Bank, CFO and Sr. VP
David Godwin, Senior Vice President-Global Business

Stock Performance Indicators

Did you try this?

Run Fund Screener Now


Fund Screener

Find activelly-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module

Currently Active Assets on Macroaxis

Purchased over 50 shares of
few hours ago
Traded for 1.0
Purchased over 50 shares of
few hours ago
Traded for 1.0
Purchased over 10K shares of
few hours ago
Traded for 1.0
Purchased over 10K shares of
few hours ago
Traded for 1.0
Purchased few shares of
few hours ago
Traded for 1.0
Additionally take a look at Your Equity Center. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Search macroaxis.com